Chenglin Mu

Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms

Chenglin Mu, Yifan Sheng, Qian Wang et al. · Journal of Functional Foods · 2020 · 130 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Generation of particle assemblies mimicking enzymatic activity by processing of herbal food: the case of rhizoma polygonati and other natural ingredients in traditional Chinese medicine

Enrico Benassi, Haiyan Fan, Qinglei Sun et al. · Nanoscale Advances · 2021 · 60 citations · Full text

Life Sciences, Biochemistry, Biotechnology +15

Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19

Fang Sun, Chenglin Mu, Hang Fai Kwok et al. · International Journal of Biological Sciences · 2021 · 45 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine

Bexultan Kazybay, Ashfaq Ahmad, Chenglin Mu et al. · Travel Medicine and Infectious Disease · 2021 · 36 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +8

Nano-evolution and protein-based enzymatic evolution predicts novel types of natural product nanozymes of traditional Chinese medicine: cases of herbzymes of Taishan-Huangjing (<i>Rhizoma polygonati</i>) and Goji (<i>Lycium chinense</i>)

Guldan Nazarbek, Aidana Kutzhanova, Lazzat Nurtay et al. · Nanoscale Advances · 2021 · 26 citations · Full text

Life Sciences, Biochemistry, Bioinformatics +17